# Etoricoxib With Flavoxate for Reducing Morphine Requirement After Transurethral Prostatectomy (TURP)

> **NCT00440739** · PHASE4 · COMPLETED · sponsor: **Mahidol University** · enrollment: 128 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** etoricoxib
- **DRUG:** flavoxate
- **DRUG:** etoricoxib, flavoxate
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00440739
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2009-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00440739

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00440739, "Etoricoxib With Flavoxate for Reducing Morphine Requirement After Transurethral Prostatectomy (TURP)". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT00440739. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*